Newsroom
January 4, 2023
Researchers at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases are researching early indicators of diseases to either prevent or delay the onset of severe symptoms.
December 8, 2022
The AHEAD clinical trial will assess whether the new Alzheimer’s drug, lecanemab, can delay the onset of dementia in persons who are at high risk of developing the disease. The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, part of The University of Texas Health Science Center at San Antonio (UT Health San Antonio), […]
October 27, 2022
In this new season, host Kitty Eisele will explore the importance of how caregivers for loved ones with dementia are portrayed in popular culture.
October 5, 2022
Holy mackerel! Could eating salmon, cod, tuna, herring or sardines keep our brains healthy and our thinking agile in middle age? New research makes this connection. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Oct. 5, 2022) — Eating cold-water fish and other sources of omega-3 fatty acids may preserve brain health and enhance cognition in […]
September 22, 2022
Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Sept. 22, 2022) — Debra Gutierrez of Von Ormy, Texas, near San Antonio has been an active person all her life. An ophthalmology technician at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), she works in a clinic that sees scores […]
June 17, 2022
An experimental brain injury medication conceived in laboratories at UT Health San Antonio was tested Tuesday, June 14, in the first human subject. If the drug, called AST-004, performs well in human studies, it will be an urgently needed and novel treatment for stroke and traumatic brain injury victims, including those with concussions.
